Deciphera Pharmaceuticals, Inc. Patent Applications Pending
16 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-12-09: Application 63287873; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
- 2021-12-09: Application 63287866; Invention RAF KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
- 2021-12-09: Application 63287857; Invention KIT INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
- 2021-12-03: Application 63285833; Invention GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2021-12-09 | 63287873 | RAF KINASE INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Daniel L. Flynn Yu Mi Ahn Lakshminarayana Vogeti Bertrand LeBourdonnec | United States United States United States United States | ||
| 2021-12-09 | 63287866 | RAF KINASE INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Daniel L. Flynn Yu Mi Ahn Lakshminarayana Vogeti Bertrand LeBourdonnec | United States United States United States United States | ||
| 2021-12-09 | 63287857 | KIT INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Yu Mi Ahn Timothy Caldwell Daniel L. Flynn Bertrand LeBourdonnec | United States United States United States United States | ||
| 2021-12-03 | 63285833 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Yu Mi Ahn Gada Al-Ani Daniel L. Flynn Salim Javed Patrick Kearney Bertrand LeBourdonnec Kristen Stoltz Jeffery Zwicker | United States United States United States United States United States United States United States United States | ||
| 2021-11-24 | PCTUS2021060762 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-24 | PCTUS2021060758 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-24 | PCTUS2021060747 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-24 | PCTUS2021060743 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-24 | PCTUS2021060742 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-24 | PCTUS2021060740 | ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN | United States | ||
| 2021-11-17 | PCTUS2021059678 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN PATRICK KEARNEY JEFFERY ZWICKER BERTRAND LEBOURDONNEC SALIM JAVED YU MI AHN KRISTEN STOLTZ GADA AL-ANI | United States United States United States United States United States United States United States United States | ||
| 2021-08-13 | 63232983 | COMBINATION THERAPY USING VPS34 INHIBITORS | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Yasmin Yu Martin Andersson | Sweden Sweden | ||
| 2021-08-10 | 63231384 | METHODS OF TREATING MELANOMA WITH RIPRETINIB | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Rodrigo Ruiz Soto Ying Su | United States United States | ||
| 2021-05-12 | 63187903 | METHODS OF TREATING MELANOMA WITH RIPRETINIB | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Rodrigo Ruiz Soto Ying Su | United States United States | ||
| 2021-05-07 | 63185846 | GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Patrick Kearney Jeffery Zwicker Salim Javed Yu Mi Ahn Kristin Stoltz Bertrand LeBourdonnec Daniel L. Flynn Gada Al-Ani | United States United States United States United States United States United States United States United States | ||
| 2021-03-05 | PCTUS2021021069 | METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS | DECIPHERA PHARMACEUTICALS, LLC | RO PROCESSING COMPLETED-PLACED IN STORAGE | RODRIGO RUIZ SOTO KEISUKE KUIDA HAROUN ACHOUR | United States United States United States |